Thrombelastography change after bridging to left ventricular assist device from extracorporeal membrane oxygenation patients

Chun Yang Huang, I. Ming Chen, Yuan Chen Hsieh, Han Chin Tsai, Yu Ting Yuan, Zen Chung Weng, Chun Che Shih, Hsiao Huang Chang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Circulatory assist devices are applied to support patients with end-stage heart failure or circulatory collapse. Extracorporeal membrane oxygenation (ECMO) and ventricular assist device (VAD) are the two devices that are commonly used in these situations. However, in patients undergoing ECMO, complications occur more frequently and are more severe than in those with VAD, especially in patients with coagulopathy. The cause of coagulopathy is seldom reported; therefore, the current prospective study was designed to compare the coagulation status between patients who received ECMO and bridged VAD thereafter. Methods: The cases for our study were collected between December 2005 and January 2010. A total of 21 patients with VAD were enrolled. Seven patients received initial ECMO support and were subsequently shifted to VAD. Use of blood transfusion products by patients was recorded during application of ECMO and VAD. Thrombelastography (TEG) was performed pre-ECMO and pre-VAD, and thereafter to 1 week post-VAD implantation. The relevant parameters that were examined included coagulation time (R: resting, K: kinetics, seconds), angle (α, degrees), maximal amplitude (MA, mm), clot strength (G, dynes/cm2), and estimated percent lysis in 30 minutes (LY30, %). Coagulation status and average unit per day of blood transfusion at pre-VAD and post-VAD status were recorded. TEGs of pre-VAD and post-VAD implantation were compared in order to determine the frequency of bleeding. Results: Average results from seven cases were incorporated into the current analysis. The patient transfusion requirement was reduced after implantation of the VAD. The TEG of post-VAD implantation was improved from the earlier pre-VAD results (ECMO status). Ultimately, TEG resulted in significant differences in R, K, angle, MA, and G, postoperatively. Conclusion: Coagulopathy of patients with VAD improved after bridging from ECMO, which can be attributed to improved coagulation factor and platelet function. Thus, bleeding complications are reduced.

Original languageEnglish
Pages (from-to)363-369
Number of pages7
JournalJournal of the Chinese Medical Association
Volume75
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Thrombelastography
Extracorporeal Membrane Oxygenation
Heart-Assist Devices
Blood Transfusion
Hemorrhage
Equipment and Supplies
Blood Coagulation Factors

Keywords

  • Artificial heart
  • ECMO
  • VAD
  • Ventricular-assisted device

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Thrombelastography change after bridging to left ventricular assist device from extracorporeal membrane oxygenation patients. / Huang, Chun Yang; Chen, I. Ming; Hsieh, Yuan Chen; Tsai, Han Chin; Yuan, Yu Ting; Weng, Zen Chung; Shih, Chun Che; Chang, Hsiao Huang.

In: Journal of the Chinese Medical Association, Vol. 75, No. 8, 08.2012, p. 363-369.

Research output: Contribution to journalArticle

Huang, Chun Yang ; Chen, I. Ming ; Hsieh, Yuan Chen ; Tsai, Han Chin ; Yuan, Yu Ting ; Weng, Zen Chung ; Shih, Chun Che ; Chang, Hsiao Huang. / Thrombelastography change after bridging to left ventricular assist device from extracorporeal membrane oxygenation patients. In: Journal of the Chinese Medical Association. 2012 ; Vol. 75, No. 8. pp. 363-369.
@article{91d9d81c1c6c423da99e19755d9a1c9b,
title = "Thrombelastography change after bridging to left ventricular assist device from extracorporeal membrane oxygenation patients",
abstract = "Background: Circulatory assist devices are applied to support patients with end-stage heart failure or circulatory collapse. Extracorporeal membrane oxygenation (ECMO) and ventricular assist device (VAD) are the two devices that are commonly used in these situations. However, in patients undergoing ECMO, complications occur more frequently and are more severe than in those with VAD, especially in patients with coagulopathy. The cause of coagulopathy is seldom reported; therefore, the current prospective study was designed to compare the coagulation status between patients who received ECMO and bridged VAD thereafter. Methods: The cases for our study were collected between December 2005 and January 2010. A total of 21 patients with VAD were enrolled. Seven patients received initial ECMO support and were subsequently shifted to VAD. Use of blood transfusion products by patients was recorded during application of ECMO and VAD. Thrombelastography (TEG) was performed pre-ECMO and pre-VAD, and thereafter to 1 week post-VAD implantation. The relevant parameters that were examined included coagulation time (R: resting, K: kinetics, seconds), angle (α, degrees), maximal amplitude (MA, mm), clot strength (G, dynes/cm2), and estimated percent lysis in 30 minutes (LY30, {\%}). Coagulation status and average unit per day of blood transfusion at pre-VAD and post-VAD status were recorded. TEGs of pre-VAD and post-VAD implantation were compared in order to determine the frequency of bleeding. Results: Average results from seven cases were incorporated into the current analysis. The patient transfusion requirement was reduced after implantation of the VAD. The TEG of post-VAD implantation was improved from the earlier pre-VAD results (ECMO status). Ultimately, TEG resulted in significant differences in R, K, angle, MA, and G, postoperatively. Conclusion: Coagulopathy of patients with VAD improved after bridging from ECMO, which can be attributed to improved coagulation factor and platelet function. Thus, bleeding complications are reduced.",
keywords = "Artificial heart, ECMO, VAD, Ventricular-assisted device",
author = "Huang, {Chun Yang} and Chen, {I. Ming} and Hsieh, {Yuan Chen} and Tsai, {Han Chin} and Yuan, {Yu Ting} and Weng, {Zen Chung} and Shih, {Chun Che} and Chang, {Hsiao Huang}",
year = "2012",
month = "8",
doi = "10.1016/j.jcma.2012.06.004",
language = "English",
volume = "75",
pages = "363--369",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "8",

}

TY - JOUR

T1 - Thrombelastography change after bridging to left ventricular assist device from extracorporeal membrane oxygenation patients

AU - Huang, Chun Yang

AU - Chen, I. Ming

AU - Hsieh, Yuan Chen

AU - Tsai, Han Chin

AU - Yuan, Yu Ting

AU - Weng, Zen Chung

AU - Shih, Chun Che

AU - Chang, Hsiao Huang

PY - 2012/8

Y1 - 2012/8

N2 - Background: Circulatory assist devices are applied to support patients with end-stage heart failure or circulatory collapse. Extracorporeal membrane oxygenation (ECMO) and ventricular assist device (VAD) are the two devices that are commonly used in these situations. However, in patients undergoing ECMO, complications occur more frequently and are more severe than in those with VAD, especially in patients with coagulopathy. The cause of coagulopathy is seldom reported; therefore, the current prospective study was designed to compare the coagulation status between patients who received ECMO and bridged VAD thereafter. Methods: The cases for our study were collected between December 2005 and January 2010. A total of 21 patients with VAD were enrolled. Seven patients received initial ECMO support and were subsequently shifted to VAD. Use of blood transfusion products by patients was recorded during application of ECMO and VAD. Thrombelastography (TEG) was performed pre-ECMO and pre-VAD, and thereafter to 1 week post-VAD implantation. The relevant parameters that were examined included coagulation time (R: resting, K: kinetics, seconds), angle (α, degrees), maximal amplitude (MA, mm), clot strength (G, dynes/cm2), and estimated percent lysis in 30 minutes (LY30, %). Coagulation status and average unit per day of blood transfusion at pre-VAD and post-VAD status were recorded. TEGs of pre-VAD and post-VAD implantation were compared in order to determine the frequency of bleeding. Results: Average results from seven cases were incorporated into the current analysis. The patient transfusion requirement was reduced after implantation of the VAD. The TEG of post-VAD implantation was improved from the earlier pre-VAD results (ECMO status). Ultimately, TEG resulted in significant differences in R, K, angle, MA, and G, postoperatively. Conclusion: Coagulopathy of patients with VAD improved after bridging from ECMO, which can be attributed to improved coagulation factor and platelet function. Thus, bleeding complications are reduced.

AB - Background: Circulatory assist devices are applied to support patients with end-stage heart failure or circulatory collapse. Extracorporeal membrane oxygenation (ECMO) and ventricular assist device (VAD) are the two devices that are commonly used in these situations. However, in patients undergoing ECMO, complications occur more frequently and are more severe than in those with VAD, especially in patients with coagulopathy. The cause of coagulopathy is seldom reported; therefore, the current prospective study was designed to compare the coagulation status between patients who received ECMO and bridged VAD thereafter. Methods: The cases for our study were collected between December 2005 and January 2010. A total of 21 patients with VAD were enrolled. Seven patients received initial ECMO support and were subsequently shifted to VAD. Use of blood transfusion products by patients was recorded during application of ECMO and VAD. Thrombelastography (TEG) was performed pre-ECMO and pre-VAD, and thereafter to 1 week post-VAD implantation. The relevant parameters that were examined included coagulation time (R: resting, K: kinetics, seconds), angle (α, degrees), maximal amplitude (MA, mm), clot strength (G, dynes/cm2), and estimated percent lysis in 30 minutes (LY30, %). Coagulation status and average unit per day of blood transfusion at pre-VAD and post-VAD status were recorded. TEGs of pre-VAD and post-VAD implantation were compared in order to determine the frequency of bleeding. Results: Average results from seven cases were incorporated into the current analysis. The patient transfusion requirement was reduced after implantation of the VAD. The TEG of post-VAD implantation was improved from the earlier pre-VAD results (ECMO status). Ultimately, TEG resulted in significant differences in R, K, angle, MA, and G, postoperatively. Conclusion: Coagulopathy of patients with VAD improved after bridging from ECMO, which can be attributed to improved coagulation factor and platelet function. Thus, bleeding complications are reduced.

KW - Artificial heart

KW - ECMO

KW - VAD

KW - Ventricular-assisted device

UR - http://www.scopus.com/inward/record.url?scp=84865352293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865352293&partnerID=8YFLogxK

U2 - 10.1016/j.jcma.2012.06.004

DO - 10.1016/j.jcma.2012.06.004

M3 - Article

C2 - 22901719

AN - SCOPUS:84865352293

VL - 75

SP - 363

EP - 369

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 8

ER -